Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 72 | 55↓23.0% | 51↓7.2% | 57↑11.8% | 64↑12.1% |
| Gross Profit | 72 | -138↓292.5% | -12↑91.3% | 17↑239.5% | 64↑283.2% |
| Operating Income | -298 | -258↑13.4% | -92↑64.3% | -56↑39.1% | -47↑16.2% |
| Net Income | -278 | -199↑28.3% | 872↑537.3% | -55↓106.3% | -56↓2.2% |
| EBITDA | -288 | -233↑19.1% | -76↑67.3% | -52↑32.1% | -38↑25.5% |
| EPS Diluted | -4.46 | -2.87↑35.7% | -1.26↑56.1% | -1.00↑20.6% | -1.15↓15.0% |